[Exclusive Webinar] Overcoming Metabolic Barriers: Modeling T Cell Dysfunction in Tumor Microenvironments
-
The tumor microenvironment (TME) is a highly complex ecosystem where cancer cells, immune cells, and metabolites constantly interact, ultimately dictating the success or failure of anti-tumor immunity.
As tumors progress, they create a harsh, metabolically challenging environment. The severe depletion of nutrients, coupled with the accumulation of immunosuppressive metabolites and altered signaling, puts immense pressure on immune cells. This metabolic stress is a primary driver of T cell dysfunction and immune evasion, severely limiting the effectiveness of current cancer immunotherapies.
To help researchers navigate and overcome these challenges, Creative Biolabs invites you to an exclusive, free webinar led by renowned immunology expert Greg M. Delgoffe, Ph.D.
️ Webinar Details
Topic: Modeling T Cell Dysfunction in Tumor Microenvironments
Date & Time: September 1, 2026 | 10:00 AM EDT
Featured Speaker: Greg M. Delgoffe, Ph.D. (Professor of Immunology, University of Pittsburgh; Associate Director for Basic Research & Director of the Tumor Microenvironment Center at the UPMC Hillman Cancer Center)
Why You Should Attend
Traditional models often fail to capture the intricate crosstalk between tumor metabolism and immune regulation. Understanding these metabolic conditions is absolutely critical for developing next-generation therapeutic strategies.
In this session, Dr. Delgoffe will explore advanced approaches for modeling the TME in preclinical research systems. From metabolically distinct tumor models to defined immunologic stress conditions, you will discover how these cutting-edge models provide physiologically relevant environments to investigate T cell dysfunction and therapeutic responses.
Key Learning Objectives:
The Metabolic Toll: How tumor metabolic environments contribute to immune suppression and T cell dysfunction.
Preclinical Strategies: Advanced methods for accurately modeling TME conditions in preclinical research systems.
Immune Evasion: How metabolically distinct tumors reveal hidden mechanisms of immune escape.
T Cell Biology: The specific impacts of nutrient depletion and toxic metabolic byproducts on T cell function and exhaustion.
Translational Opportunities: How novel insights into immunometabolism can guide the development and enhancement of next-generation cancer immunotherapies.
Who Should Attend?
Cancer Immunologists studying tumor immunity and immune suppression mechanisms.
Scientists & Researchers focused on immunotherapy, T cell biology, and immunometabolism.
R&D Professionals in pharma and biotech involved in oncology drug discovery and immune checkpoint therapies.
Translational Researchers seeking advanced preclinical models to better understand immune-tumor interactions.
️ Secure Your Spot Today!
Don't miss this opportunity to gain actionable insights from a leading expert in immunometabolism and TME research.
Click the link below to register for free: 
Register Now: Modeling T Cell Dysfunction in Tumor Microenvironments
Spaces are limited. Register early to ensure your access to the live session and Q&A!
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Register Login
